The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease

Rotigotine is a new, non-ergot dopamine receptor agonist (DRA) formulated as a transdermal drug delivery system. This article reviews the clinical efficacy and tolerability of Rotigotine transdermal patch in Parkinson's disease (PD) and discusses the results of clinical trials of Rotigotine in...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: Marina Romanovna Nodel
Format: Artigo
Langue:Russo
Publié: IMA-PRESS LLC 2013-11-01
Collection:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Sujets:
parkinson's disease
levodopa
dopamine receptor agonists
rotigotine
transdermal patch
therapy
compliance
fluctuations
dyskinesis
Accès en ligne:https://nnp.ima-press.net/nnp/article/view/257
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires